Tag: letrozoleFemara

Femara: An aromatase inhibitor used to treat ER+ breast cancer. Aromatase inhibitors are designed to inhibit the action of the enzyme aromatase, which converts androgens into estrogens within the body. Femara is the trade name of letrozole.

Articles

News

04/30/13
Unpleasant side effects of anti-estrogens can indicate treatment is working
12/31/12
Treatment with Femara after tamoxifen can worsen cholesterol profile
07/19/12
Aromatase inhibitors are less effective in reducing estrogen in women with high BMI
09/07/11
Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
07/17/11
Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
11/18/10
Aromatase inhibitors have numerous side effects in addition to musculoskeletal symptoms

Studies